✦ LIBER ✦

Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma

✍ Scribed by Ramin Altaha; Edward Crowell; Gerry Hobbs; Gerry Higa; Jame Abraham

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 40 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival in patients with brain metastas

Survival in patients with brain metastases from breast cancer : The importance of HER-2 status

✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i

Disruption of the blood brain barrier by

Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer

✍ Kan Yonemori; Koji Tsuta; Makiko Ono; Chikako Shimizu; Akihiro Hirakawa; Tadashi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views

Kinetics of serum HER-2/neu changes in p

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy

✍ Chafika Mazouni; Angeline Hall; Kristine Broglio; Herbert Fritsche; Fabrice Andr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Serum HER-2/neu conversion to positive a

Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy

✍ Allan Lipton; Kim Leitzel; Suhail M. Ali; Laurence Demers; Harold A. Harvey; Hil 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

The risk of central nervous system metas

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma

✍ Filippo Montemurro; Massimo Aglietta 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

The risk of central nervous system metas

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma

✍ Rose Lai; Chau T. Dang; Mark G. Malkin; Lauren E. Abrey 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

## Abstract ## BACKGROUND Trastuzumab, which is a large monoclonal antibody that is efficacious in the treatment of patients with HER‐2/__neu__‐overexpressing, metastatic breast carcinoma, does not penetrate the blood‐brain barrier and, thus, may allow the brain to become a sanctuary site for micr